Cargando…
Total CroFab and Anavip Antivenom Vial Administration in US Rattlesnake Envenomations: 2019–2021
INTRODUCTION: In 2018, Anavip became available for the treatment of rattlesnake envenomations in the USA. No comparisons between the treatment characteristics of patients have been made since Anavip and CroFab have both been widely available. The objective of this study was to compare the number of...
Autores principales: | Brandehoff, Nicklaus, Dalton, Alicia, Daugherty, Claire, Dart, Richard C., Monte, Andrew A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293487/ https://www.ncbi.nlm.nih.gov/pubmed/37115482 http://dx.doi.org/10.1007/s13181-023-00941-7 |
Ejemplares similares
-
Pediatric Rattlesnake Envenomation: A Simulation Scenario With Optional Health Equity, Virtual Facilitation, and Senior Learner Modifications
por: Joseph, Melissa N, et al.
Publicado: (2021) -
Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: An integrative review
por: Lavonas, Eric J, et al.
Publicado: (2009) -
Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015) -
Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria
por: Habib, Abdulrazaq G., et al.
Publicado: (2015) -
Comparison of F(ab')(2) versus Fab antivenom for pit viper envenomation: A prospective, blinded, multicenter, randomized clinical trial
por: Bush, Sean P., et al.
Publicado: (2015)